Withaferin A binding potential and interaction to the catalytic site of BCR-ABL, an oncogenic protein promoting cell proliferation and inhibition of apoptosis in chronic myeloid leukemia (CML), was determined as a result of computational analysis (Malik et al., 2022). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.